BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34649308)

  • 1. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
    Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
    Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway.
    Xu GR; Zhang C; Yang HX; Sun JH; Zhang Y; Yao TT; Li Y; Ruan L; An R; Li AY
    Biomed Pharmacother; 2020 Jun; 126():110071. PubMed ID: 32172066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
    Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
    Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Yuan J; Hong H; Zhang Y; Lu J; Yu Y; Bi X; Wang J; Ye J
    Cell Biol Int; 2019 Jun; 43(6):695-705. PubMed ID: 30977566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
    Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
    Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
    Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) signaling pathway.
    Chen Z; Zhou H; Huang X; Wang S; Ouyang X; Wang Y; Cao Q; Yang L; Tao Y; Lai H
    Bioengineered; 2022 May; 13(5):12772-12782. PubMed ID: 35609321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.
    Zhao LG; Li PL; Dai Y; Deng JL; Shan MY; Chen B; Zhang KB; Guo SD; Xu ZH
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):246-254. PubMed ID: 32433360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
    Zhang Y; Shang Z; Liu A
    Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction.
    Ali SS; Mohamed SFA; Rozalei NH; Boon YW; Zainalabidin S
    Cardiovasc Toxicol; 2019 Feb; 19(1):72-81. PubMed ID: 30128816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis.
    Althurwi HN; Abdel-Kader MS; Alharthy KM; Salkini MA; Albaqami FF
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Citrus Pectin Prevents Blood-Brain Barrier Disruption in Mouse Subarachnoid Hemorrhage by Inhibiting Galectin-3.
    Nishikawa H; Liu L; Nakano F; Kawakita F; Kanamaru H; Nakatsuka Y; Okada T; Suzuki H
    Stroke; 2018 Nov; 49(11):2743-2751. PubMed ID: 30355205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
    Beckles DL; Mascareno E; Siddiqui MA
    Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors.
    Ola A; Kerkelä R; Tokola H; Pikkarainen S; Skoumal R; Vuolteenaho O; Ruskoaho H
    Br J Pharmacol; 2010 Feb; 159(3):717-25. PubMed ID: 20067472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxifolin ameliorates DEHP-induced cardiomyocyte hypertrophy via attenuating mitochondrial dysfunction and glycometabolism disorder in chicken.
    Cai J; Shi G; Zhang Y; Zheng Y; Yang J; Liu Q; Gong Y; Yu D; Zhang Z
    Environ Pollut; 2019 Dec; 255(Pt 1):113155. PubMed ID: 31539850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4.
    Tian Y; Lv W; Lu C; Jiang Y; Yang X; Song M
    Can J Physiol Pharmacol; 2020 Oct; 98(10):700-707. PubMed ID: 32516552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.